50 research outputs found
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease
Introduction: Inflammation contributes to cardiovascular disease and is exacerbated with
increased adiposity, particularly omental adiposity; however, the role of epicardial fat is poorly
understood.
Methods: For these studies the expression of inflammatory markers was assessed in epicardial fat
biopsies from coronary artery bypass grafting (CABG) patients using quantitative RT-PCR. Further,
the effects of chronic medications, including statins, as well as peri-operative glucose, insulin and
potassium infusion, on gene expression were also assessed. Circulating resistin, CRP, adiponectin
and leptin levels were determined to assess inflammation.
Results: The expression of adiponectin, resistin and other adipocytokine mRNAs were
comparable to that in omental fat. Epicardial CD45 expression was significantly higher than control
depots (p < 0.01) indicating significant infiltration of macrophages. Statin treated patients showed
significantly lower epicardial expression of IL-6 mRNA, in comparison with the control abdominal
depots (p < 0.001). The serum profile of CABG patients showed significantly higher levels of both
CRP (control: 1.28 ± 1.57 Όg/mL vs CABG: 9.11 ± 15.7 Όg/mL; p < 0.001) and resistin (control:
10.53 ± 0.81 ng/mL vs CABG: 16.8 ± 1.69 ng/mL; p < 0.01) and significantly lower levels of
adiponectin (control: 29.1 ± 14.8 Όg/mL vs CABG: 11.9 ± 6.0 Όg/mL; p < 0.05) when compared to
BMI matched controls.
Conclusion: Epicardial and omental fat exhibit a broadly comparable pathogenic mRNA profile,
this may arise in part from macrophage infiltration into the epicardial fat. This study highlights that
chronic inflammation occurs locally as well as systemically potentially contributing further to the
pathogenesis of coronary artery disease
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease
BACKGROUND: The recent recognition that coronary-artery stenting has improved the short- and long-term outcomes of patients treated with angioplasty has made it necessary to reevaluate the relative benefits of bypass surgery and percutaneous interventions in patients with multivessel disease. METHODS: A total of 1205 patients were randomly assigned to undergo stent implantation or bypass surgery when a cardiac surgeon and an interventional cardiologist agreed that the same extent of revascularization could be achieved by either technique. The primary clinical end point was freedom from major adverse cardiac and cerebrovascular events at one year. The costs of hospital resources used were also determined. RESULTS: At one year, there was no significant difference between the two groups in terms of the rates of death, stroke, or myocardial infarction. Among patients who survived without a stroke or a myocardial infarction, 16.8 percent of those in the stenting group underwent a second revascularization, as compared with 3.5 percent of those in the surgery group. The rate of event-free survival at one year was 73.8 percent among the patients who received stents and 87.8 percent among those who underwent bypass surgery (P<0.001 by the log-rank test). The costs for the initial procedure were 2,973 per patient. CONCLUSION: As measured one year after the procedure, coronary stenting for multivessel disease is less expensive than bypass surgery and offers the same degree of protection against death, stroke, and myocardial infarction. However, stenting is associated with a greater need for repeated revascularization
Getting shot of elves: healing, witchcraft and fairies in the Scottish witchcraft trials
This paper re-examines the evidence of the Scottish witchcraft trials for beliefs associated by scholars with "elf-shot." Some supposed evidence for elf-shot is dismissed, but other material illuminates the interplay between illness, healing and fairy-lore in early modern Scotland, and the relationship of these beliefs to witchcraft itself
An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup
BACKGROUND. Chronic obstructive pulmonary disease (COPD) is a heterogeneous smoking-related disease characterized by airway obstruction and inflammation. This inflammation may persist even after smoking cessation and responds variably to corticosteroids. Personalizing treatment to biologically similar "molecular phenotypes" may improve therapeutic efficacy in a COPD. IL-17A is involved in neutrophilic inflammation and corticosteroid resistance, and thus may be particularly important in a COPD molecular phenotype. METHODS. We generated a gene expression signature of IL-17A response in bronchial airway epithelial brushings from smokers with and without COPD (n = 238) , and validated it using data from 2 randomized trials of IL-17 blockade in psoriasis. This IL-17 signature was related to clinical and pathologic characteristics in 2 additional human studies of COPD: (a) SPIROMICS (n = 47), which included former and current smokers with COPD, and (b) GLUCOLD (n = 79), in which COPD participants were randomized to placebo or corticosteroids. RESULTS. The IL-17 signature was associated with an inflammatory profile characteristic of an IL-17 response, including increased airway neutrophils and macrophages. In SPIROMICS the signature was associated with increased airway obstruction and functional small airways disease on quantitative chest CT. In GLUCOLD the signature was associated with decreased response to corticosteroids, irrespective of airway eosinophilic or type 2 inflammation. CONCLUSION. These data suggest that a gene signature of IL-17 airway epithelial response distinguishes a biologically, radiographically, and clinically distinct COPD subgroup that may benefit from personalized therapy
Small-scale and regional spatial dynamics of an annual plant with contrasting sexual systems
Plant demography is known to depend on both spatial dynamics and life history, but how these two factors interact is poorly understood. We conducted a longitudinal study of the wind-pollinated annual plant Mercurialis annua that varies geographically in its sexual system to investigate this interaction.
Metapopulation demographic models predict that regular population turnover should be a more common feature of monomorphic than dimorphic populations because males and females cannot found new populations by selfing but hermaphrodites can. We tested the prediction that rates of population turnover would be higher in monomorphic compared to dimorphic regions.
We surveyed 356 populations of M. annua along five regional transects in Morocco and the Iberian Peninsula over a 3-year period to examine their demography and persistence. Each transect crossed a transition in the sexual system, from a monomorphic region where almost all populations were hermaphroditic to a dimorphic one in which most populations had separate sexes (males with females or hermaphrodites).
As predicted, rates of local apparent extinctions (i.e., the disappearance of adult plants) were nearly 50% higher in monomorphic compared to dimorphic regions. Local extinctions appeared to be driven by changes in vegetation cover, with extinctions tending to occur in sites in which perennial cover also declined. This suggests that disturbance is a primary agent of local extinctions.
We further examined the influence of regional dynamics on local demographic properties by investigating patterns of spatial autocorrelation in population density across years. We found positive spatial autocorrelations in plant densities within regions for both sexual systems. However, these positive autocorrelations extended over shorter distances in monomorphic regions, perhaps as a result of greater population flux in these regions.
Synthesis. Our study shows that population dynamics may be influenced by processes acting at a range of spatial scales: within patches, across patches within sites, and across sites within regions, as well as by life-history variation. In Mercurialis annua, regional variation in apparent extinction rates is affected by life history and implicated in regulating the geographical distribution of populations with different sexual systems
Global urban environmental change drives adaptation in white clover
Urbanization transforms environments in ways that alter biological evolution. We examined whether urban environmental change drives parallel evolution by sampling 110,019 white clover plants from 6169 populations in 160 cities globally. Plants were assayed for a Mendelian antiherbivore defense that also affects tolerance to abiotic stressors. Urban-rural gradients were associated with the evolution of clines in defense in 47% of cities throughout the world. Variation in the strength of clines was explained by environmental changes in drought stress and vegetation cover that varied among cities. Sequencing 2074 genomes from 26 cities revealed that the evolution of urban-rural clines was best explained by adaptive evolution, but the degree of parallel adaptation varied among cities. Our results demonstrate that urbanization leads to adaptation at a global scale
Localized Rhabdomyolysis After Exertion in a Cardiac Transplant Recipient on Statin Therapy
Assessment of the Potential Heart Donor:A Role for Biomarkers?
Demand for donor hearts exceeds supply, and a significant number of patients die while awaiting transplantation. Within the pool of currently unused potential donor hearts, a proportion may be suitable for transplantation but are declined due to anticipated poor function. Despite current assessment methods, in some donor hearts accepted for transplantation early graft failure develops in the recipient. Current methods of assessment are inadequate, and there is a potential for biomarkers to improve identification of satisfactory hearts for transplantation or hearts destined to fail in the recipient. Biomarkers are routinely used to diagnose and risk-stratify myocardial infarction, acute coronary syndromes, and heart failure. Some of these might facilitate donor heart assessment. Cardiac troponins, cytokines, inflammatory markers, natriuretic peptides, and intracellular proteins may each have discriminant value. This review details the current status of biomarkers in the assessment of donor hearts